Mesa Laboratories Inc
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and clean… Read more
Mesa Laboratories Inc (MLAB) - Total Liabilities
Latest total liabilities as of December 2025: $248.16 Million USD
Based on the latest financial reports, Mesa Laboratories Inc (MLAB) has total liabilities worth $248.16 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Mesa Laboratories Inc - Total Liabilities Trend (1988–2025)
This chart illustrates how Mesa Laboratories Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Mesa Laboratories Inc Competitors by Total Liabilities
The table below lists competitors of Mesa Laboratories Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ripley Corp
SN:RIPLEY
|
Chile | CL$2.89 Trillion |
|
Comba Telecom Systems Holdings Limited
PINK:COBJF
|
USA | $4.73 Billion |
|
Liaoning Oxiranchem Inc
SHE:300082
|
China | CN¥2.60 Billion |
|
Robinsons Land Corporation
PINK:RBLAF
|
USA | $91.98 Billion |
|
Farglory Land Development Co Ltd
TW:5522
|
Taiwan | NT$64.70 Billion |
|
Grupo Mateus S.A
SA:GMAT3
|
Brazil | R$12.44 Billion |
|
BSR Real Estate Investment Trust
PINK:BSRTF
|
USA | $832.27 Million |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥1.12 Billion |
Liability Composition Analysis (1988–2025)
This chart breaks down Mesa Laboratories Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Mesa Laboratories Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Mesa Laboratories Inc (1988–2025)
The table below shows the annual total liabilities of Mesa Laboratories Inc from 1988 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $273.52 Million | -9.25% |
| 2024-03-31 | $301.40 Million | +12.32% |
| 2023-03-31 | $268.35 Million | -14.42% |
| 2022-03-31 | $313.57 Million | +60.60% |
| 2021-03-31 | $195.25 Million | -2.47% |
| 2020-03-31 | $200.19 Million | +340.41% |
| 2019-03-31 | $45.46 Million | -29.79% |
| 2018-03-31 | $64.74 Million | -12.41% |
| 2017-03-31 | $73.91 Million | -2.84% |
| 2016-03-31 | $76.07 Million | +73.51% |
| 2015-03-31 | $43.84 Million | +32.07% |
| 2014-03-31 | $33.20 Million | +152.13% |
| 2013-03-31 | $13.17 Million | +94.16% |
| 2012-03-31 | $6.78 Million | -53.45% |
| 2011-03-31 | $14.57 Million | +496.52% |
| 2010-03-31 | $2.44 Million | +21.37% |
| 2009-03-31 | $2.01 Million | +12.15% |
| 2008-03-31 | $1.79 Million | +9.99% |
| 2007-03-31 | $1.63 Million | +6.53% |
| 2006-03-31 | $1.53 Million | +25.80% |
| 2005-03-31 | $1.22 Million | +43.85% |
| 2004-03-31 | $846.00K | +25.70% |
| 2003-03-31 | $673.06K | +24.08% |
| 2002-03-31 | $542.45K | -38.78% |
| 2001-03-31 | $886.01K | -5.22% |
| 2000-03-31 | $934.80K | +33.54% |
| 1999-03-31 | $700.00K | +16.67% |
| 1998-03-31 | $600.00K | 0.00% |
| 1997-03-31 | $600.00K | -25.00% |
| 1996-03-31 | $800.00K | +33.33% |
| 1995-03-31 | $600.00K | -14.29% |
| 1994-03-31 | $700.00K | -30.00% |
| 1993-03-31 | $1.00 Million | +66.67% |
| 1992-03-31 | $600.00K | 0.00% |
| 1991-03-31 | $600.00K | -25.00% |
| 1990-03-31 | $800.00K | +300.00% |
| 1989-03-31 | $200.00K | +100.00% |
| 1988-03-31 | $100.00K | -- |